GD2IL18CART is a type of cell therapy where a patient’s own immune cells (T cells) are modified in a laboratory to better recognize and fight cancer cells. These modified cells are engineered to target a specific protein called GD2 that is found on some cancer cells, and they also contain a component called IL18 which helps boost the immune response. This is an investigational therapy being studied for its long-term effects in patients who have previously received this treatment.

Neuroblastoma – A cancer that develops from immature nerve cells, most commonly starting in the adrenal glands but can also develop in other areas. It typically occurs in young children and can present as a lump or mass in the abdomen, chest, or neck. The disease can spread to other parts of the body including bones and bone marrow.

Osteosarcoma – A type of bone cancer that typically develops in the growing bones of children and adolescents. It usually starts in areas where the bone grows quickly, such as near the ends of long bones, particularly around the knee and upper arm. The affected bone may become painful and swollen.

Ewing Sarcoma – A rare type of cancer that occurs in bones or in the soft tissue around bones. It most commonly affects children and young adults, typically appearing in the pelvis, leg bones, or chest wall. The affected area may become painful and swollen, sometimes accompanied by fever.

Advanced Breast Cancer – A stage of breast cancer where cancer cells have spread beyond the original tumor site to other parts of the body. It develops when abnormal cells in breast tissue multiply and grow uncontrollably. The disease can affect nearby lymph nodes and spread to other organs through the bloodstream or lymphatic system.